Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11294	Companies
250971	Keywords
179884	Articles
136841	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 09/11/2026 at 07:00, 1 month 27 days ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Biophytis annonce une augmentation de capital de 5,3 millions d'euros pour financer l'essai de phase 2 dans l'obésité. L'opération est équilibrée entre investisseurs américains et européens

Biophytis Augmentation De Capital Investisseurs Essai Clinique Obésité
REGULATED PRESS RELEASE

published on 09/11/2026 at 07:00, 1 month 27 days ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Biophytis completes €5.3 million capital increase to fund Phase 2 trial in obesity, balancing US and European investors. Proceeds target fat loss and muscle preservation with BIO101

Biophytis Capital Increase Phase 2 Trial BIO101 Obesity
BRIEF

published on 08/31/2026 at 07:05, 2 months 8 days ago

Biophytis Strengthens Financial Position with Cash Runway into 2027

Biophytis Debt Reduction Financial Restructuring Clinical Studies Share Warrants
BRIEF

published on 08/31/2026 at 07:05, 2 months 8 days ago

Biophytis renforce sa trésorerie et planifie de nouvelles études cliniques

Biophytis Actions En Circulation Études Cliniques Trésorerie Renforcée Diminution De La Dette
REGULATED PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027. Position de trésorerie renforcée à 3,0 millions d'euros. Démarrage de l'étude de phase II dans l'obésité et joint-venture à Hong Kong sur le point de démarrer ses activités

Biophytis Hong Kong Trésorerie Obésité Phase II
REGULATED PRESS RELEASE

published on 08/31/2026 at 07:00, 2 months 8 days ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position, extends cash runway to Q1 2027. Cash inflows of €3.7M, debt reduction of over 30%. Phase 2 study in obesity in Q1 2027

Biophytis Financial Position Debt Reduction Obesity Study Cash Runway
PRESS RELEASE

published on 08/31/2026 at 06:59, 2 months 8 days ago

Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027
Biophytis renforce sa situation financière en étendant son horizon de trésorerie au T1 2027 grâce à l'exercice des bons de souscription d'actions 2026 et à la réduction de sa dette. Démarrage imminent d'une étude de phase II dans l'obésité

Biophytis Restructuration Financière Trésorerie Étude Clinique Obésité
PRESS RELEASE

published on 08/31/2026 at 06:59, 2 months 8 days ago

Biophytis strengthens its financial position and extends its cash runway into Q1 2027
Biophytis strengthens financial position and extends cash runway to Q1 2027 through new resources and debt reduction, starting Phase 2 obesity study in Q1 2027

Biophytis Financial Position Debt Reduction Phase 2 Study Cash Runway
BRIEF

published on 08/10/2026 at 07:05, 2 months 29 days ago

Biophytis Secures Approval for OBA Clinical Trial in Brazil

Biophytis Obesity Treatment BIO101 GLP-1 Therapies OBA Clinical Trial
BRIEF

published on 08/10/2026 at 07:05, 2 months 29 days ago

Biophytis lance l'étude clinique OBA au Brésil avec BIO101

Biophytis Brésil BIO101 Obésité OBA Étude

Accesswire

Published on 11/06/2026 at 22:15, 2 days 5 hours ago

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 14 hours ago

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 15 hours ago

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 15 hours ago

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 10:00, 2 days 17 hours ago

Mongolia Tax Audit

View all ACCESSWIRE

EQS Group

Published on 11/09/2026 at 01:55, 1 hour 40 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 15 hours 25 minutes ago

GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 17 hours 20 minutes ago

2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 14 hours ago

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 7 hours ago

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing

Les Echos

Published on 11/06/2026 at 19:06, 2 days 8 hours ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 8 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 8 hours ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 8 hours ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 18:00, 2 days 9 hours ago

ICADE - CP - Notation crédit S&P

View all LES ECHOS COMFI WIRE